Description
Apremilast is a phthalimide derivative that acts as a phosphodiesterase inhibitor (PDE-4 inhibitor). As a result, fewer inflammatory factors (TNF-α) are released. The substance is used for medium to severe, chronic plaque psoriasis and psoriasisarthritis. It was approved in the US in 2014 and the EU in 2015.